Literature DB >> 7913175

Arthropathy in thalassaemia patients receiving deferiprone.

F N al-Refaie, B Wonke, A V Hoffbrand.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7913175     DOI： 10.1016/s0140-6736(94)93029-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  Deferiprone: a review of its clinical potential in iron overload in beta-thalassaemia major and other transfusion-dependent diseases.

Authors:  J A Barman Balfour; R H Foster
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546

2.  [Arthropathy in beta-thalassemia minor].

Authors:  J Richter; C Specker; U Mödder; M Schneider
Journal:  Med Klin (Munich)       Date:  2000-01-15

3.  Prevalence and characteristics of inflammatory rheumatic diseases in patients with thalassemia.

Authors:  Pokpong Piriyakhuntorn; Adisak Tantiworawit; Nuntana Kasitanon; Worawit Louthrenoo
Journal:  Ann Hematol       Date:  2022-05-23       Impact factor: 4.030
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.